BLTE SEC Filings: 8-K, 10-Q, S-3 & 424B – Belite Bio

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 31, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 17, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 11, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 31, 2023

News

TYPE

HEADLINE

FILED AT

6-K

Belite Bio Announces Uplisting to the Nasdaq Global Select Market

Oct 19, 2026

6-K

Belite Bio Submits New Drug Application in Japan for Tinlarebant under Sakigake Designation for Stargardt Disease Type 1

Sep 8, 2026

6-K

Belite Bio Reports Q2 2026 Financial Results and FDA Acceptance of Tinlarebant NDA

Aug 12, 2026

6-K

Belite Bio Announces FDA Acceptance and Priority Review of NDA for Tinlarebant

Aug 11, 2026

6-K

Belite Bio Completes Rolling NDA Submission to FDA for Tinlarebant

Jun 12, 2026

6-K

Belite Bio Reports Q1 2026 Financial Results and Progress on Tinlarebant NDA Submission

May 20, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

FIXED PRICE OFFERING - AMERICAN DEPOSITARY SHARES | Offering amount: $349,999,958 | Shares: 2,272,727 | Price: $154.000 | Bank: Morgan Stanley

Dec 2, 2025

424B5

PENDING FIXED PRICE OFFERING | Bank: Morgan Stanley, Leerink Partners, BofA Securities, Cantor

Dec 1, 2025

424B5

FIXED PRICE OFFERING | Offering amount: $15,000,050 | Shares: 230,770 | Price: $65.000 | Bank: Titan Partners Group LLC

Aug 8, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Feb 7, 2025

424B7

Form 424B7 - Prospectus [Rule 424(b)(7)]

Jan 27, 2025

424B5

Shares amount: 651,380 | Warrants amount: 651,380 | Warrants exercise price: $44.14

Apr 29, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 30, 2026

F-3ASR

Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Oct 22, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 21, 2025

F-3ASR

Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Jan 27, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Oct 1, 2024

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 19, 2023

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

Belite Bio, Inc BLTE · SEC Filings